Integrated Lifestyle-Based Cardiovascular Prevention Targeting Metabolic Syndrome Implications for Primary and Secondary Risk Reduction

سال انتشار: 1404
نوع سند: مقاله کنفرانسی
زبان: انگلیسی
مشاهده: 32

فایل این مقاله در 7 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

MEDHEAL01_023

تاریخ نمایه سازی: 3 اسفند 1404

چکیده مقاله:

Background: Cardiovascular disease (CVD) remains the leading cause of mortality worldwide. Metabolic syndrome, a cluster of interrelated cardiometabolic abnormalities, significantly increases the risk of both incident and recurrent cardiovascular events. While pharmacological therapies are well established, lifestyle-based preventive strategies remain under-implemented in routine clinical practice.Objective: To comprehensively evaluate integrated lifestyle-based interventions—including nutrition, physical activity, behavioral modification, and sport medicine—in the prevention of cardiovascular disease among individuals with metabolic syndrome, with emphasis on both primary and secondary prevention.Methods: A narrative review was conducted using PubMed, Scopus, and Web of Science databases, focusing on randomized controlled trials, meta-analyses, and large cohort studies published in high-impact journals. Evidence was synthesized to assess the clinical effectiveness, feasibility, and translational potential of lifestyle-based cardiovascular prevention strategies.Results: Robust evidence indicates that structured lifestyle interventions significantly improve metabolic parameters, reduce systemic inflammation, and lower the incidence of major adverse cardiovascular events. Combined dietary and exercise-based interventions demonstrate superior outcomes compared to isolated strategies, particularly when implemented early and sustained long-term. Conclusion: Integrated lifestyle-based prevention targeting metabolic syndrome is a cornerstone of effective cardiovascular risk reduction. Multidisciplinary, patient-centered approaches are essential for translating evidence into durable clinical benefit.

نویسندگان

Seyed Mostafa Tabatabaei

Internal Medicine Resident Shahid Beheshti University of Medical Sciences, Tehran, Iran

Sara Soltani

MSc Department of Pharmaceutical Chemistry Tehran Medical Sciences, Islamic Azad University, Tehran, Iran